GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Liwanli Innovation Co Ltd (TPE:3054) » Definitions » EV-to-Revenue

Liwanli Innovation Co (TPE:3054) EV-to-Revenue : 19.32 (As of May. 25, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Liwanli Innovation Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Liwanli Innovation Co's enterprise value is NT$1,283.90 Mil. Liwanli Innovation Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$66.44 Mil. Therefore, Liwanli Innovation Co's EV-to-Revenue for today is 19.32.

The historical rank and industry rank for Liwanli Innovation Co's EV-to-Revenue or its related term are showing as below:

TPE:3054' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.33   Med: 6.45   Max: 44.72
Current: 19.33

During the past 13 years, the highest EV-to-Revenue of Liwanli Innovation Co was 44.72. The lowest was 0.33. And the median was 6.45.

TPE:3054's EV-to-Revenue is ranked worse than
91.6% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs TPE:3054: 19.33

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Liwanli Innovation Co's stock price is NT$20.15. Liwanli Innovation Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.82. Therefore, Liwanli Innovation Co's PS Ratio for today is 24.51.


Liwanli Innovation Co EV-to-Revenue Historical Data

The historical data trend for Liwanli Innovation Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liwanli Innovation Co EV-to-Revenue Chart

Liwanli Innovation Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.47 5.46 32.89 36.07 34.46

Liwanli Innovation Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.11 39.36 38.59 34.46 19.99

Competitive Comparison of Liwanli Innovation Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Liwanli Innovation Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liwanli Innovation Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Liwanli Innovation Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Liwanli Innovation Co's EV-to-Revenue falls into.



Liwanli Innovation Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Liwanli Innovation Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1283.896/66.442
=19.32

Liwanli Innovation Co's current Enterprise Value is NT$1,283.90 Mil.
Liwanli Innovation Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$66.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liwanli Innovation Co  (TPE:3054) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Liwanli Innovation Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=20.15/0.822
=24.51

Liwanli Innovation Co's share price for today is NT$20.15.
Liwanli Innovation Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.82.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liwanli Innovation Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Liwanli Innovation Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Liwanli Innovation Co (TPE:3054) Business Description

Traded in Other Exchanges
N/A
Address
Liancheng Road,, 16Floor-1, No.258,, Zhonghe District, New Taipei City, TWN, 235
Liwanli Innovation Co Ltd is engaged in the manufacture, wholesale, and retail of electronic materials and sales of biotech products like drug nutrient products. The company earns maximum revenue from Biotech products.

Liwanli Innovation Co (TPE:3054) Headlines

No Headlines